In 2020, the European open surgery instrument market will be severely impacted by the COVID-19 pandemic. However, the open surgery instrument market in Europe will grow marginally throughout the forecast period. While the use of open surgery instruments continues to increase—driven by the uptake of innovative premium-priced products—declining open procedure volumes will continue to hinder overall market growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in Europe across a 10-year period.
The US open surgery instrument market will grow modestly through 2028.
Which open surgery instrument market will see the strongest growth in US?
Which device segments will decline in size?
The increasing uptake of robotic-assisted laparoscopy will occur at the expense of open procedures.
Which procedures will be most affected by this trend?
Why are some procedures more affected by this trend than others?
Surgeons and health care facilities are increasingly opting to use advanced direct energy devices for open surgical procedures.
What factors drive the use of advanced energy devices, and for which surgeries?
Will ASPs decline as a result of this increased demand?
- Open Surgery Instruments - Market Insights - Europe
Author(s): Lucy Sha Guan, MSc
Lucy Guan is a senior analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, with extensive knowledge in the markets for endoscope servicing, video and high-tech hardware devices, and laparoscopic devices. Lucy holds an Honors Bachelor's degree in Biochemistry and Health & Disease and a Master's degree in Medical Science from the University of Toronto.